Clinical Trial Update: Bioequivalence Study of Clindamycin Phosphate Topical Lotion, 1% in Subjects With Acne Vulgaris [Phase 3]

View source ↗

Summary

Phase 3 bioequivalence study of clindamycin phosphate 1% topical lotion for acne vulgaris completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acne Vulgaris

Drugs mentioned

• Clindamycin Phosphate Topical Lotion 1% (clindamycin phosphate topical lotion)

Snippet

Sponsor: Balmoral Medical company | Conditions: Acne Vulgaris | Phase 3 | Status: COMPLETED | Results posted: 2021-05-04